Kailera Therapeutics, Inc. (KLRA)

11.16 -0.17 (-1.50%) USD  |  NASDAQ  |  Oct 13, 10:40
More

Kailera Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for KLRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Diluted (Quarterly YoY Growth) Data

View and export this data back to . Start Trial.
Date Value

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Twist Bioscience Corp. Upgrade
Prime Medicine, Inc. Upgrade
GRAIL, Inc. Upgrade
Arrowhead Pharmaceuticals, Inc. Upgrade
Oncolytics Biotech, Inc. Upgrade